Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients
NCT ID: NCT01550042
Last Updated: 2024-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
4 participants
OBSERVATIONAL
2011-09-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Follow-up of Kryptogenic Stroke Patients With Implantable vs. Non-invasive Devices to Detect Atrial Fibrillation.
NCT02641678
Detection of Occult Paroxysmal Atrial Fibrillation After Stroke Using Prolonged Ambulatory Cardiac Monitoring
NCT01325545
Finding Atrial Fibrillation in Stroke - Evaluation of Enhanced and Prolonged Holter Monitoring
NCT01855035
SCREENING AFTER STROKE - ATRIAL FIBRILLATION
NCT06675383
Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events
NCT05134454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intensive observation cohort
Patients \> 18 years of age diagnosed with a recent episode of cryptogenic stroke with long term rhythm observation using an implantable loop recorder for detecting atrial fibrillation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undetermined etiology with negative evaluation (including cardioembolism work- up) according to the criteria for the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
* Implantation of an implantable loop recorder within two months after index event
* Able of providing informed consent
Exclusion Criteria
* Untreated hyperthyroidism
* Indication for pacemaker implantation, implantable cardioverter defibrillator (ICD) or Cardiac Resynchronisation Therapy (CRT)
* Severe co-morbidity not likely to complete follow-up for one year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medisch Spectrum Twente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
B. Oude Velthuis
Research fellow electrophysiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcoen Scholten, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Medisch Spectrum Twente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medisch Spectrum Twente / Thoraxcenter
Enschede, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Thoraxcenter
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P11-25
Identifier Type: OTHER
Identifier Source: secondary_id
NL36491.044.11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.